BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vaswani B, Bhagat S, Patil S, Barkate H. Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India. World J Clin Oncol 2020; 11(8): 606-613 [PMID: 32879847 DOI: 10.5306/wjco.v11.i8.606]
URL: https://www.wjgnet.com/2218-4333/full/v11/i8/606.htm
Number Citing Articles
1
Bharat Vaswani, Palanki S Dattatreya, Hanmant Barkate, Sagar B Bhagat, Saiprasad Patil, Amit Y Jadhav. The Effectiveness of an Oral Fixed-Dose Combination of Netupitant and Palonosetron (NEPA) in Patients With Multiple Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Observational Indian StudyCureus 2022;  doi: 10.7759/cureus.29094
2
Boman Dhabhar, Prabrajya N Mahapatra, Vamshi M Krishna, Jatin Sarin, Tara Chand Gupta, Aseem Samar, Bivas Biswas, Aditya Murli, Rajesh Kota, Suyash Bharat, Richa Tripathi. Expert Consensus Guidance on the Management of Chemotherapy-Induced Nausea and Vomiting: An Indian PerspectiveCureus 2025;  doi: 10.7759/cureus.84070
3
Pragya Shukla, Shaunak Valame, Siddhartha Nanda, Naval K Shakya, Arun K Verma, Abhinandan Hanji, Amullya Pednekar, Sagar Bhagat, Saiprasad Patil, Anup U Petare, Sumit Bhushan, Hanmant Barkate. STOP-CINV Study: Safety and Efficacy of IV Akynzeo® (Fosnetupitant 235 mg and Palonosetron 0.25 mg) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Indian PatientsCureus 2025;  doi: 10.7759/cureus.91965
4
Akhil Kapoor, Ashutosh Jain, Abhishek Sharma, Minit Shah, Shravan Chinthala, Ravindra Nandhana, Prabhat Bhargava, Anant Ramaswamy, Sujay Srinivas, Vikas Ostwal. Chemotherapy-Induced Nausea and Vomiting in Gastrointestinal Cancer Patients: Do We Need to Revisit Guidelines?South Asian Journal of Cancer 2020; 9(04): 245 doi: 10.1055/s-0041-1729493